Evidence map›Paper›PMID 41461900›Full record

ArticleNature cardiovascular research2026

A multimodal vision knowledge graph of cardiovascular disease.

Khaled Rjoob, Kathryn A McGurk, Sean L Zheng, Lara Curran, Mahmoud Ibrahim, Lingyao Zeng, Vladislav Kim, Shamin Tahasildar, Soodeh Kalaie, Deva S Senevirathne and 8 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Khaled RjoobMRC Laboratory of Medical Sciences, Imperial College London, London, UK.
Kathryn A McGurkMRC Laboratory of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-5445-6906
Sean L ZhengMRC Laboratory of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-5762-6392
Lara CurranNational Heart and Lung Institute, Imperial College London, London, UK.
Mahmoud IbrahimBayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.
Lingyao ZengBayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.
Vladislav KimBayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.
Shamin TahasildarMRC Laboratory of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0009-0000-1463-9997
Soodeh KalaieMRC Laboratory of Medical Sciences, Imperial College London, London, UK.
Deva S SenevirathneMRC Laboratory of Medical Sciences, Imperial College London, London, UK.
Parisa GifaniMRC Laboratory of Medical Sciences, Imperial College London, London, UK.
Vladimir LosevMRC Laboratory of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-9677-7022
Jin ZhengMRC Laboratory of Medical Sciences, Imperial College London, London, UK.
Wenjia BaiDepartment of Computing, Department of Brain Sciences and Data Science Institute, Imperial College London, London, UK.ORCID http://orcid.org/0000-0003-2943-7698
Antonio de MarvaoMRC Laboratory of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0001-9095-5887
James S WareMRC Laboratory of Medical Sciences, Imperial College London, London, UK.ORCID http://orcid.org/0000-0002-6110-5880
Christian BenderBayer AG, Research and Development, Pharmaceuticals, Wuppertal, Germany.ORCID http://orcid.org/0000-0003-2630-1453
Declan P O'ReganMRC Laboratory of Medical Sciences, Imperial College London, London, UK. declan.oregan@imperial.ac.uk.ORCID http://orcid.org/0000-0002-0691-0270

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
Modular Automated -80C Sample Storage SystemS10OD025092 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GOLDENRING, JAMES RICHARD · 2019 to 2019
$2.0M
Automated Storage and Retrieval of Biological SystemsS10RR025141 · NCRR · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2008 to 2008
$988k
BioVU Plasma Storage EquipmentS10OD017985 · OD · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2014 to 2014
$239k
British Heart Foundation (BHF) BBC/F/21/220106British Heart Foundation (BHF) CH/F/24/90015British Heart Foundation (BHF) FS/IPBSRF/22/27059British Heart Foundation (BHF) RE/24/130023British Heart Foundation (BHF) RG/F/24/110138NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NCRR NIH HHS S10 RR025141NCRR NIH HHS UL1 RR024975NIH HHS S10 OD017985NIH HHS S10 OD025092RCUK | Medical Research Council (MRC) MC_UP_1605/13Sir Jules Thorn Charitable Trust 21JTA
6 · The paper itself

Abstract

Understanding gene-disease associations is important for uncovering pathological mechanisms and identifying potential therapeutic targets. Knowledge graphs can represent and integrate data from multiple biomedical sources, but lack individual-level information on target organ structure and function. Here we develop CardioKG, a knowledge graph that integrates over 200,000 computer vision-derived cardiovascular phenotypes from biomedical images with data extracted from 18 biological databases to model over a million relationships. We used a variational graph auto-encoder to generate node embeddings from the knowledge graph to predict gene-disease associations, assess druggability and identify drug repurposing strategies. The model predicted genetic associations and therapeutic opportunities for leading causes of cardiovascular disease, which were associated with improved survival. Candidate therapies included methotrexate for heart failure and gliptins for atrial fibrillation, and the addition of imaging data enhanced pathway discovery. These capabilities support the use of biomedical imaging to enhance graph-structured models for identifying treatable disease mechanisms.

Indexed as

Cardiovascular DiseasesComputational BiologyComputer GraphicsCardiovascular AgentsDatabases, FactualDrug RepositioningGenetic Predisposition to DiseaseHumansPhenotypeCardiovascular Agents

Identifiers

PMID41461900
PMCPMC12811117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.